WallStreetZen

NYSE: TMO
Thermo Fisher Scientific Inc Stock Forecast, Predictions & Price Target

Analyst price target for TMO

Based on 14 analysts offering 12 month price targets for Thermo Fisher Scientific Inc.
Min Forecast
$340.00-32.42%
Avg Forecast
$495.43-1.53%
Max Forecast
$550.00+9.31%

Should I buy or sell TMO stock?

Strong Buy
Strong Buy
10 analysts 66.67%
Buy
2 analysts 13.33%
Hold
3 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is TMO forecast to generate an efficient return?
Company
24.36%
Industry
-0.21%
Market
60.43%
TMO's Return on Equity is forecast to be high in 2 years (24.36%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is TMO forecast to generate an efficient return on assets?
Company
12.1%
Industry
9.22%
Market
15%
TMO is forecast to generate higher Return on Assets (12.1%) than the US Diagnostics & Research industry average (9.22%)
Forecast

TMO earnings per share forecast

What is TMO's earnings per share in the next 2 years based on estimates from 10 analysts?
Avg 1 year Forecast
$19.96+62.29%
Avg 2 year Forecast
$19.60+59.33%
TMO's earnings are forecast to grow at an exceptional rate of 62.29% per year
Forecast

TMO revenue forecast

What is TMO's revenue in the next 2 years based on estimates from 7 analysts?
Avg 1 year Forecast
$33.1B+16.29%
Avg 2 year Forecast
$33.0B+15.8%
TMO's revenue is forecast to grow at a rate of 16.29% per year, which is not exceptional
Forecast

TMO earnings growth forecast

How is TMO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
62.29%
Industry
70.99%
Market
110.74%
TMO's earnings are forecast to grow slower (62.29% per year) than the US Diagnostics & Research industry average (70.99%)
Forecast
TMO's earnings are forecast to grow slower (62.29% per year) than the US market average (110.74%)
Forecast
TMO's earnings are forecast to grow faster (62.29% per year) than the risk-free savings rate (1.1%)
Forecast

TMO revenue growth forecast

How is TMO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
16.29%
Industry
21.21%
Market
71.81%
TMO's revenues are forecast to grow slower (16.29% per year) than the US Diagnostics & Research industry average (21.21%)
Forecast
TMO's revenues are forecast to grow slower (16.29% per year) than the US market average (71.81%)
Forecast

Thermo Fisher Scientific Stock Forecast FAQ

Is Thermo Fisher Scientific Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NYSE: TMO) stock is to Strong Buy TMO stock.

Out of 15 analysts, 10 (66.67%) are recommending TMO as a Strong Buy, 2 (13.33%) are recommending TMO as a Buy, 3 (20%) are recommending TMO as a Hold, 0 (0%) are recommending TMO as a Sell, and 0 (0%) are recommending TMO as a Strong Sell.

What is TMO's Price Target?

According to 14 Wall Street analysts that have issued a 1 year TMO price target, the average TMO price target is $495.43, with the highest TMO stock price forecast at $550.00 and the lowest TMO stock price forecast at $340.00.

On average, Wall Street analysts predict that Thermo Fisher Scientific's share price could fall to $495.43 by Jan 7, 2022. The average Thermo Fisher Scientific stock price prediction forecasts a potential downside of 1.53% from the current TMO share price of $503.14.

What is TMO's earnings growth forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's forecast annual earnings growth rate of 62.29% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 70.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 110.74%.

Thermo Fisher Scientific's earnings in 2020 is $4,879,000,000.On average, 10 Wall Street analysts forecast TMO's earnings for 2021 to be $7,896,755,603, with the lowest TMO earnings forecast at $7,001,932,380, and the highest TMO earnings forecast at $8,346,936,340.

In 2022, TMO is forecast to generate $7,752,563,267 in earnings, with the lowest earnings forecast at $7,120,609,200 and the highest earnings forecast at $8,588,245,874.

What is TMO's revenue growth forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 16.29% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 21.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.81%.

Thermo Fisher Scientific's revenue in 2020 is $28,497,000,000.On average, 7 Wall Street analysts forecast TMO's revenue for 2021 to be $13,108,987,737,042, with the lowest TMO revenue forecast at $12,753,992,138,912, and the highest TMO revenue forecast at $13,519,267,745,000.

In 2022, TMO is forecast to generate $13,054,706,146,342 in revenue, with the lowest revenue forecast at $12,619,301,860,000 and the highest revenue forecast at $13,467,758,049,226.

What is TMO's Earnings Per Share (EPS) forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's current Earnings Per Share (EPS) is $12.30. On average, analysts forecast that TMO's EPS will be $19.96 for 2021, with the lowest EPS forecast at $17.70, and the highest EPS forecast at $21.10. In 2022, TMO's EPS is forecast to hit $19.60 (min: $18.00, max: $21.71).

What is TMO's forecast return on equity (ROE) for 2021-2022?

(NYSE: TMO) forecast ROE is 24.36%, which is considered strong.

What is TMO's forecast return on assets (ROA) for 2021-2022?

(NYSE: TMO) forecast ROA is 12.1%, which is higher than the forecast US Diagnostics & Research industry average of 9.22%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics